Business & Finance

How Trump's psychedelics executive order could unlock stalled cannabis reform

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.

By · April 20, 2026 · 1 min read

This article was originally published by CNBC Top News and is republished here under license.

The White House psychedelics executive order accelerates research, clinical trials and “Right to Try” access for drugs like psilocybin, MDMA and ibogaine.

Related

Why Brad Jacobs' QXO Is Buying TopBuild in $17 Billion Deal

Business & Finance

Why Brad Jacobs' QXO Is Buying TopBuild in $17 Billion Deal

QXO CEO Brad Jacobs explains why the company is acquiring insulation company TopBuild Corp. for about $17 billion on "Bloomberg The Close."…

By · April 20, 2026 · 1 min read

DRAM ETF Surpasses $1B Assets Since Early April Launch

Business & Finance

DRAM ETF Surpasses $1B Assets Since Early April Launch

Bloomberg Intelligence's Jake Silverman joins Katie Greifeld, Scarlet Fu, and Eric Balchunas on "Bloomberg ETF IQ." The Roundhill Memory ETF…

By · April 20, 2026 · 1 min read

Romania Coalition Nears Collapse as Top Party Spurns Premier

Business & Finance

Romania Coalition Nears Collapse as Top Party Spurns Premier

Romania’s government has been thrown into turmoil after the top ruling party withdrew its support for Prime Minister Ilie Bolojan,…

By · April 20, 2026 · 1 min read

Leave a ReplyCancel reply